Extended release formulation of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61K 9/20 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2570096

The present invention relates to an extended release formulation of 3-amino-8- (1~piperazinyl)-2H-1-benzopyran-2-one or a pharmaceutically acceptable salt thereof or a hydrate of said pharmaceutically acceptable salt thereof. The invention further relates to the preparation of these extended release formulations and their use in the prevention or treatment of disorders, especially pain and CNS disorders such as depression, anxiety and movement disorders.

La présente invention concerne une préparation à libération prolongée de 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one, ou d'un sel pharmaceutiquement acceptable de ce composé, ou bien d'un hydrate pharmaceutiquement acceptables dudit sel. De plus, l'invention concerne la fabrication des ces préparations à libération prolongée et leur utilisation pour le traitement préventif ou curatif de certains troubles, en particulier de la douleur et de troubles du SNC tels que la dépression, l'angoisse et les troubles des mouvements.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Extended release formulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extended release formulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release formulation of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1966911

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.